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Background: Low back pain is a common and costly condition. There are several treatment options for people
suffering from back pain, but there are few data on how to improve patients’ treatment choices. This study will
test the effects of a decision support package (DSP), designed to help patients seeking care for back pain to make
better, more informed choices about their treatment within a physiotherapy department. The package will be
designed to assist both therapist and patient.
Methods/Design: Firstly, in collaboration with physiotherapists, patients and experts in the field of decision
support and decision aids, we will develop the DSP. The work will include: a literature and evidence review;
secondary analysis of existing qualitative data; exploration of patients’ perspectives through focus groups and
exploration of experts’ perspectives using a nominal group technique and a Delphi study.
Secondly, we will carry out a pilot single centre randomised controlled trial within NHS Coventry Community
Physiotherapy. We will randomise physiotherapists to receive either training for the DSP or not. We will randomly
allocate patients seeking treatment for non specific low back pain to either a physiotherapist trained in decision
support or to receive usual care. Our primary outcome measure will be patient satisfaction with treatment at three
month follow-up. We will also estimate the cost-effectiveness of the intervention, and assess the value of
conducting further research.
Discussion: Informed shared decision-making should be an important part of any clinical consultation, particularly
when there are several treatments, which potentially have moderate effects. The results of this pilot will help us
determine the benefits of improving the decision-making process in clinical practice on patient satisfaction.
Trial registration: Current Controlled Trials ISRCTN46035546
Background
Low back pain (LBP) is a common, disabling and expen-
sive disorder. In 1998 treating this condition cost the
National Health Service (NHS) £1,632M [1]. The 2009
National Institute for Health and Clinical Excellence
(NICE) guidelines for early management of persistent
non-specific LBP [2] recommend that clinicians consider
offering patients with chronic LBP a course of one of a
range of different therapies (acupuncture, exercise, man-
ual therapy), depending on the patient’sp r e f e r e n c e .
These therapies have modest average benefits at a mod-
est cost. The clinical effects and the costs of these differ-
ent treatments are of a similar magnitude, so there is no
clear basis for preferring any one of these treatments for
use in the NHS. It is, however, possible that improved
matching of patients to treatments will produce a
greater overall positive effect. An understanding of the
factors that inform patient choice and decision-making
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for themselves. Having the opportunity to participate in
such decision-making may also be associated with better
health outcomes [3,4].
A patient-centred approach, using shared decision-
making (SDM), involves the patient and healthcare pro-
fessional discussing treatment options and interacting to
agree on a management plan [5,6]. This approach is
widely advocated but its use in practice is challenging
[7]. SDM involves taking patient expectations, prefer-
ences, concerns, ideas and values, plus the practitioner’s
values and experiences into account. In contrast,
informed decision-making involves presenting patients
with relevant information and options without the
healthcare professional expressing a preference. This
‘informed model’ g i v e sp a t i e n t sa u t o n o m yb u tf a i l st o
take into account the shared interaction [8]. The
patient-practitioner interaction model represents
‘informed shared decision-making’ (ISDM) and is the
model that will be used to design a decision support
package (DSP) for LBP patients. The quality of patient-
practitioner interactions may be crucially important in
improving back pain outcomes [9].
Coaching to support patients’ making decisions is
effective in aiding patients’ knowledge, information
recall, and participation in decision-making [10]. Deci-
sion aids are ‘interventions designed to help people
make specific and deliberate choices among options by
providing information about the options and outcomes
relevant to a person’s health status’ [10]. These aids pro-
vide information to facilitate patients’ involvement in
the decision-making process. Patient expectations and
preferences also play a role in decision-making and may
affect outcomes. Patients with a higher expectation of
recovery have reported higher functional improvement
[11]. Within randomised controlled trials (RCTs) in gen-
eral, those randomised to their preferred treatment gain
more benefit [12]. However, evidence from RCTs of
LBP is equivocal: one RCT of LBP found that those who
expected better outcomes with treatment gained more
benefit than those who did not; however another trial
failed to show that expectations affected outcome
[13,14]. Patient preferences may also affect treatment
adherence [15].
Patients report they would like to play an active role
in decisions concerning their health [16]. Many patients
also want a patient-centred approach to decision-making
incorporating communication, partnership and health
promotion [17]. However it is important to remember
that while not all patients want to be involved in deci-
sion-making all of the time, they should be given choice
about the depth of involvement. Clinicians do not
always involve patients in decision-making; possibly
because they feel ill trained to do so [18]. Despite this,
general practitioners (GPs)h a v ep o s i t i v ev i e w sa b o u t
SDM and can gain the skills required to implement
SDM in practice [19,20].
The aim of this pilot RCT is to develop and test the
effect of a DSP on patient satisfaction. This package will
comprise material to assist both the physiotherapist and
patient during the informed shared decision-making
process. Overall, the DSP will be designed to help
patients seeking care for back pain, make informed
choices, about their treatment which are the best for
them.
Methods/Design
This pilot has been funded by the National Institute of
Health Research - Research for Patient Benefit Pro-
gramme (Ref: PB-PG-0808-17039). Ethical approval has
been granted by Warwickshire Research Ethics Commit-
tee (Ref: 10/H1211/2).
Intervention design
To inform the design of the DSP, we will conduct a series
of exploratory studies (described in more detail below).
This work will be carried out in collaboration with phy-
siotherapists, patients, and experts in the field of decision
support and decision aids. At this time it is difficult to
predict the exact nature of the DSP - this will depend on
the findings from our exploratory work. However, we
anticipate that there will be: an information package that
summarises the nature of each intervention; a rationale
for the interventions, questions that assist the patient in
reviewing their current health status and the value they
place on possible future scenarios, and what is known
about the effectiveness of the interventions.
In a recent Cochrane review of decision aids for peo-
ple facing health treatment or screening decisions, the
included studies used a variety of decision aids for a
range of conditions. A sample of some of the decision
aids included were cancer treatments and screening,
back surgery, hormone replacement therapy and osteo-
porosis treatments. The decision aids varied in formats
including video tapes, computer based interactive pro-
grammes, audio material and information booklets [21].
Some decision aids were available in a combination of
formats giving patients options. Our DSP will be
designed to enable easy implementation into routine
NHS care. This will be suitable for use by both patients
and therapists. We anticipate that once this package has
been developed, we will devise a formal training pro-
gramme to deliver to physiotherapists to improve their
knowledge of the treatment options and their skills in
ISDM. We will integrate patients’ and therapists’ views
on the content and format of our decision support pack-
age. We will subsequently publish a paper describing the
intervention in detail.
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the Coventry Community Physiotherapy team to test
the intervention in an uncontrolled manner, allowing us
to test practicality and feasibility in the clinical environ-
ment. We will assess this by direct observation of the
consultation process and through focus groups with
patients and physiotherapists. This will allow us to opti-
mise the intervention before starting the pilot RCT.
The section below describes the exploratory work to
be undertaken to inform the intervention design.
A. Literature & evidence review
We will review relevant new trial data published since the
2009 National Institute for Health and Clinical Excellence
(NICE) guidelines on low back pain [2]. This will allow us
to identify any new data that, if available to the guideline
development group, may have led to a change of recom-
mendations. We will only include RCTs of therapist deliv-
ered interventions with a sample size >349. This is the
sample size beyond which an RCT can detect a standar-
dised effect size of 0.3 or less with 80% power and 5% sig-
nificance if there are two groups split evenly [22]. It is
such large trials that might, in the future, lead to changes
in guidance. The information about the treatments and
evidence in our DSP will be based on this NICE guidance
and subsequent trials identified from this review.
We will systematically seek studies of decision aids for
treatments for benign disorders, such as tennis elbow or
depression, with multiple moderately effective treatment
options. We will extract data about the components of
these interventions and the mechanisms by which they
are thought to act. We will use this data to inform the
design of our decision aid.
We will also systematically identify qualitative studies
of people with chronic back pain that include accounts
of why they chose different therapies. This will provide
us with some understanding of the reasoning behind
treatment choice within patients with back pain.
B. Secondary Analysis
We have interview data from people living with back
pain undertaken with individuals in both the interven-
tion and control arm of a clinical trial evaluating a
group cognitive behavioural approach for patients with
low back pain in primary care (Back Skills Training
Trial - BeST) [23]. Interviews were undertaken at 2-4
months after the intervention (or baseline assessment)
and 12 months later. The interviews include exploration
of the experience of living with back pain including the
use of interventions beyond that being evaluated in the
trial. We will re-analyse these data to identify influences
on treatment decisions and use this data in our decision
aid planning and development.
C. Patients’ perspectives
Concurrently we will develop a questionnaire to mea-
sure current patient preferences for treatment. We will
approach around 100 people seeking treatment from the
physiotherapy department for LBP. Those interested will
be asked to complete the questionnaire and subse-
quently participate in a focus group. Interested respon-
dents will provide a sampling frame for our focus
groups. Our purposive sampling willbe informed by age,
gender, duration & troublesomeness of LBP, treatment
decisions and treatment preferences. We will run two
focus groups to develop a broad understanding of the
factors that inform choice and decision-making among
patients with back pain in which we will explore: how
patients make decisions in general (i.e. decision style),
h o wt h e ym a k ed e c i s i o n sa n dc hoices about treatments
for their back pain, what information patients would
like to help them make more informed choices, and
what patients think of the existing material on offer to
them.
Qualitative data will be analysed using the framework
method to identify key concepts and themes [24].
D. Experts’ perspectives
To develop an understanding of experts’ views and
experiences of informed shared decision-making for LBP
treatments we have selected two broad areas of experts,
physiotherapists and patient experts. By engaging these
two groups we hope to generate a range of experiences
which will feed into our intervention design.
We will recruit physiotherapists, who regularly provide
first contact care for low back pain from a neighbouring
primary care trust, to a nominal group - a formal face
to face consensus method [25]. This is a structured
approach to data collection from a group who have
insight into a specific topic area. This method allows
ideas to be generated as well as solutions to be achieved.
Participants are initially asked to generate ideas, which
the group later discuss and rank in order of importance.
We have selected this method as it encourages partici-
pation from everyone and as a result we hope it will
lead to good quality ideas and solutions.
Concurrently, we will also conduct a Delphi study
with patient group leaders, expert patients and advocacy
group activists. We will work with local and national
organisations to identify expert patients who have
experience of managing back pain. We have selected the
Delphi method as it is a practical method of obtaining
opinions from a range of experts nationally. We will
develop a set of questions to send to the experts; the
responses will then be collated and fed back to the par-
ticipants for further rounds of questions. Rounds will
continue until consensus is achieved.
The results of the reviews and secondary analyses
together with the focus groups, nominal group techni-
que and the Delphi study will feed into the intervention
design. We will use the overall consensus of opinion to
help inform how we develop, and what we include, in
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time of writing to pre-judge the content and format of
the decision support package. As part of the design pro-
cess for the package we will invite comments from key
opinion leaders in back pain research nationally and
internationally to ensure that no key content has been
omitted.
Pilot RCT design
This study is a single centre randomised controlled trial
taking place in the physiotherapy service at NHS Coven-
try Community Physiotherapy. The physiotherapy ser-
vice sees around 300 patients as new back pain referrals
a month. The service uses a paper free referral system,
when patients are advised by their GP to attend the
physiotherapy service, it is the patient’s responsibility to
call the booking team and arrange an appointment.
Physiotherapists will be randomised to either receiving
training for the DSP or not. Subsequently patients will
be randomised to either a trained or a standard
physiotherapist.
Study population and eligibility criteria
One hundred and fifty participants seeking treatment
from the physiotherapy service at NHS Coventry Com-
munity Physiotherapy will be recruited. We will include
patients who have been advised by their GP to attend
physiotherapy. GPs are asked to refer those patients pre-
senting with LBP who do not return to normal activities
after 3-4 weeks. Earlier referrals can be made for
patients who are not coping with their pain e.g. the pain
has a significant effect upon daily living or they present
with poor prognosis which the GP is unable to address.
In all cases the GP would provide patients with the
Back Pain Access number. The patient is then free to
ring and directly book a 45 minute assessment appoint-
ment. GPs are asked to exclude patients if they have
signs of red flags, acute LBP of less than 3-4 weeks,
those already under secondary care, had recent lumbar
spine surgery, LBP as part of a presentation of multiple
body pains e.g. fibromyalgia, thoracic or cervical pain
and unstable psychiatric illness.
In this pilot RCT patients will be included if they are
seeking treatment for non specific LBP, they are aged
≥18 years and have fluent spoken and written English.
We will exclude patients with severe psychiatric or per-
sonality disorders, those with a terminal or critical ill-
ness and patients with possible serious spinal pathology
(e.g. tumour, infection or fracture).
Recruitment procedure
Following advice from their GP, the patient is given
i n f o r m a t i o no nh o wt og e ti nt o u c hw i t ht h eb o o k i n g
s e r v i c et om a k ea na p p o i n t m e n t( s e ef i g u r e1 ) .T h o s e
who do so will be sent an invitation to join the study.
Interested participants will return the consent form and
completed baseline questionnaire to the research team.
Patients who meet the inclusion criteria, complete the
baseline questionnaire and consent to the trial will be
included. They will be randomised to either a DSP
trained physiotherapist or usual physiotherapy care. All
participants will attend a 45 minute one-to-one assess-
ment where they will be informed of the treatments on
offer and have the opportunity to discuss these.
Randomisation
We will randomise half of the 14 (five whole time equiva-
lents) physiotherapists to deliver the intervention. Patients
will then be randomised to physiotherapists. Once the
consent form and baseline questionnaire are received, the
physiotherapy department will call the Warwick Clinical
Trials Unit randomisation service to randomise the patient
to either the control or intervention arm. Clinic lists will
be adjusted to ensure participants have appointments with
the allocated therapists: control or intervention.
Outcome assessment
Our package of outcome measures is based on those we
have used successfully in two previous large scale com-
munity based trials of LBP treatments and are in line
with international recommendations [26,27].
a. Primary outcome measure
We will use satisfaction with treatment at three months
using a five-point Likert Scale (very satisfied to very dis-
satisfied) as our primary outcome. It is an amended ver-
sion of the standardised and recommended single-item
question [28]. Since a study of this size is unlikely to
show a change in clinical outcomes, satisfaction with
treatment is a useful outcome measure that is likely to be
more sensitive to change than clinical outcomes. If, in
this pilot, we can generate some evidence that we can
improve satisfaction, we will have justification for pro-
ceeding to a trial to test the impact on clinical outcomes.
b. Secondary outcome measures
￿ Roland Morris Disability Questionnaire (RMDQ)
[29] - The most commonly used measure of LBP-
related disability in primary care trials.
￿ Modified Von Korff [30] - A measure of LBP &
disability over the preceding month.
￿ SF-12 [31] - A generic measure of health-related
quality of life.
￿ EuroQol [32] - A generic measure of health utility
that is designed for use in RCTs.
￿ Hospital Anxiety and Depression Scale (HADS)
[33] - An established and validated self rating instru-
ment for anxiety and depression.
￿ Pain Self-Efficacy Questionnaire (PSEQ) [34] - An
established measure self-efficacy for people with
chronic pain.
￿ Fear Avoidance Beliefs Questionnaire (FABQ) [35]
- The physical sub-scale of FABQ measures attitude
to movement in back pain.
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physiotherapy department’s records.
￿ Use of health services and costs
Immediate follow-up
The immediate follow-up assessment will focus on satis-
faction with the decision-making process. We will use
the ‘Satisfaction with Decision Scale’ [36]. This is a tool
used to measure satisfaction with a health care decision.
The scale has been adapted and applied to other condi-
tions [37]. We will post this questionnaire to partici-
p a n t sa n da s kt h e mt or e t u r ni tb yp o s tt ot h es t u d y
team.
Figure 1 Pilot randomised controlled trial flow chart.
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For this pilot RCT we will do a single follow-up after
three months, when treatment will be complete and
maximum benefit from treatment is expected. In addi-
tion to measuring satisfaction and repeating baseline
measures we will collect data on health service use and
health transition [38]. We will send follow-up question-
naires by post, three months after randomisation. We
will send postal reminders after two and four weeks,
and if necessary, we will collect a minimum data set by
phone from non-responders.
Sample size
In the Back Skills Training (BeST) trial, satisfaction with
treatment was measured using a five-point Likert Scale
(very satisfied to very dissatisfied) [23]. In this trial the
difference in satisfaction with treatment (a combination
of ‘somewhat satisfied’ and ‘very satisfied’)a tt h r e e
months was 23.6% compared to 54.3% for control and
treatment arm, respectively. Assuming satisfaction is
50% in the control group (similar to the treatment arm
in BeST), then to show a similar additional improve-
ment to 75% with 80% power at 5% significance level we
need data on 58 participants in each group. We have
not inflated the sample size to allow a design effect for
clustering by therapist. In our two previous trials of LBP
treatments, clustering effects by therapist were insignifi-
cant [26,27]. Thus, allowing for a 20% loss to follow up,
we need to recruit a minimum of 150 participants.
Data analysis
Descriptive summary statistics for demographic and
baseline data will be provided. The dichotomised
responses on the five point Likert scale to the treatment
satisfaction question will be analysed by means of a gen-
eralised linear mixed model with logit link, fixed effects
for intervention and baseline pain severity, and random
physiotherapist effects. The estimated intervention effect
(odds ratio) will be reported with 95% confidence inter-
val and p-value testing the null hypothesis of no inter-
vention effect. Continuous outcomes will be reported as
difference in change from baseline with its 95% confi-
dence interval.
Health economics
We will estimate the mean cost of the intervention and
other back pain-related NHS services and participants’ out
of pocket expenses over the three-month study period.
We will collect information on the cost of training for the
physiotherapists in the DSP group, including the cost of
the tutors’ time to prepare and deliver the training, the
cost of participants’ time, travel costs and materials.
Therapy cost will be collected from PCT records. The
three-month follow-up questionnaire will include ques-
tions about use of medication (prescribed and over-the-
counter), GP attendances, inpatient stays, outpatient
consultations, and visits to other therapists (NHS and
private). Healthcare cost will be estimated using unit costs
from the NHS tariff and standard references texts [39].
The ‘within-trial’ difference in mean costs and the dif-
ference in mean quality adjusted life years (QALYs) will
be estimated with 95% confidence intervals, allowing for
the effects of treatment, baseline pain severity, and treat-
ing physiotherapist. These estimates will help us to
assess the potential benefits of conducting a definitive
trial and economic evaluation. For example, if the DSP
is associated with greater healthcare costs and no appar-
ent improvement in health outcomes over this initial
three-month period, it is unlikely that further research
would be worthwhile, particularly if there is also no
clear evidence of a strong patient preference for use of
the DSP. However, if cost savings and/or health
improvements are observed, it is possible that DSP may
be a cost-effective intervention and further research
would be warranted.
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